• Skip to main content

Aphios

Inspired by Nature, Enabled by Science®

  • Products
    ▼
    • Enhanced Therapeutic Products Overview
    • Therapeutic Products Pipeline
      ▼
      • Oncology
        ▼
        • Zindol®: Ginger Extract Therapy for CINV
        • APH-0701
        • APH-0911
        • APH-0912
        • APH-0804
        • Taxosomes™
        • Camposomes™
        • Dermos™
        • APH-0201
        • Sperol™
      • Infectious Disease
        ▼
        • APH-0812
        • APH-0202
        • nanoHYP™
        • Asterias™
        • Marinus™
        • HIV/AIDS Therapeutic Vaccine
        • Anti-HIV Therapeutics
        • Anti-Influenza Therapeutics
        • Vaccine Adjuvant Technology
          ▼
          • Anthrax Vaccine Adjuvant
      • CNS Disorders
        ▼
        • APH-1104
        • Xantol™
        • APH-1501: CBD + LDN Nanotherapy for OUD
        • APH-1502: CBD Nanotherapy for CIPNP
        • APH-1503: CBD Nanotherapy for Anxiety Relief
        • APH-1504: CBD Nanotherapy for Multiple Sclerosis
        • APH-1505: CBD Nanotherapy for Epilepsy
        • APH-0802 – nanoTHC™
        • APH-1403
      • Diabetes
        ▼
        • APH-0907
    • Research Chemicals & APIs
      ▼
      • Adhyperforin
      • Adhyperforin DCHA
      • Betulin
      • Betulinic Acid
      • Bryostatin 1
      • Bryostatin 2
      • Bryostatin 3
      • Camptothecin
      • C-ATR
      • Cephalomannine: Anti-Tumor Taxane Compound from Yew Tree
      • Cyclopamine: Steroidal Alkaloid Hedgehog Pathway Inhibitor from Corn Lily
      • Cycloposine: Steroidal Alkaloid from Corn Lily (Veratrum californicum)
      • 10-DAB
      • 9-DHAB
      • Δ9-THC
      • Δ9-THCA
      • Frondoside A
      • 6-Gingerol: Bioactive Compound from Ginger Root (Zingiber officinale)
      • 8-Gingerol: Bioactive Compound from Ginger Root (Zingiber officinale)
      • 10-Gingerol: Bioactive Compound from Ginger Root (Zingiber officinale)
      • Hypericin: Photodynamic Antiviral Compound from St. John’s Wort (Hypericum perforatum)
      • Hyperforin
      • Hyperforin DCHA
      • Jervine: Steroidal Alkaloid Hedgehog Pathway Antagonist from Corn Lily (Veratrum californicum)
      • MLA
      • Muldamine: Steroidal Alkaloid from Corn Lily (Veratrum californicum)
      • Nobiletin: Polymethoxylated Flavone from Citrus Peel (Citrus sinensis)
      • Paclitaxel: Natural Anti-Mitotic Anticancer Compound from Yew (Taxus sp.)
      • Phloridzin Dihydrate: Dihydrochalcone SGLT Inhibitor from Apple Wood (Malus sp.)
      • Sclareolide: Sesquiterpene Lactone from Clary Sage (Salvia sclarea)
      • 6-Shogaol: Bioactive Compound from Ginger Root (Zingiber officinale)
      • Tangeretin: Bioflavonoid from Citrus Peel (Citrus sinensis)
      • Veratramine: Steroidal Alkaloid from Corn Lily (Veratrum californicum)
    • Equipment
    • Quality of Life Medicines
  • Technology
    ▼
    • Enabling Technology Platforms
    • Drug Discovery
    • Drug Manufacturing
    • Drug Delivery
      ▼
      • CFN
      • PNS
      • PNP
    • Drug Safety
      ▼
      • CFI™ Mechanisms of Action & Applications
    • Microbial Cell Disruption
    • Crystallization
      ▼
      • Natural Therapeutics Crystallization – CRY
      • SuperFluids Crystallization Process
    • Biomass Pretreatment
      ▼
      • Cellulosic Biomass Pretreatment (CBP) – Aosic Platform
  • Investors
    ▼
    • Investors Overview
      ▼
      • Aphios Pharma LLC
      • Aphios International LLC
      • Zindol LLC
  • About
    ▼
    • Company Overview
    • Management
    • Directors
    • Scientific Advisors
    • Community Involvement
    • Press Releases
    • Events
    • Careers
  • Contact
  • Shop
  • Products
    • Enhanced Therapeutic Products Overview
    • Therapeutic Products Pipeline
      • Oncology
        • Zindol®: Ginger Extract Therapy for CINV
        • APH-0701
        • APH-0911
        • APH-0912
        • APH-0804
        • Taxosomes™
        • Camposomes™
        • Dermos™
        • APH-0201
        • Sperol™
      • Infectious Disease
        • APH-0812
        • APH-0202
        • nanoHYP™
        • Asterias™
        • Marinus™
        • HIV/AIDS Therapeutic Vaccine
        • Anti-HIV Therapeutics
        • Anti-Influenza Therapeutics
        • Vaccine Adjuvant Technology
          • Anthrax Vaccine Adjuvant
      • CNS Disorders
        • APH-1104
        • Xantol™
        • APH-1501: CBD + LDN Nanotherapy for OUD
        • APH-1502: CBD Nanotherapy for CIPNP
        • APH-1503: CBD Nanotherapy for Anxiety Relief
        • APH-1504: CBD Nanotherapy for Multiple Sclerosis
        • APH-1505: CBD Nanotherapy for Epilepsy
        • APH-0802 – nanoTHC™
        • APH-1403
      • Diabetes
        • APH-0907
    • Research Chemicals & APIs
      • Adhyperforin
      • Adhyperforin DCHA
      • Betulin
      • Betulinic Acid
      • Bryostatin 1
      • Bryostatin 2
      • Bryostatin 3
      • Camptothecin
      • C-ATR
      • Cephalomannine: Anti-Tumor Taxane Compound from Yew Tree
      • Cyclopamine: Steroidal Alkaloid Hedgehog Pathway Inhibitor from Corn Lily
      • Cycloposine: Steroidal Alkaloid from Corn Lily (Veratrum californicum)
      • 10-DAB
      • 9-DHAB
      • Δ9-THC
      • Δ9-THCA
      • Frondoside A
      • 6-Gingerol: Bioactive Compound from Ginger Root (Zingiber officinale)
      • 8-Gingerol: Bioactive Compound from Ginger Root (Zingiber officinale)
      • 10-Gingerol: Bioactive Compound from Ginger Root (Zingiber officinale)
      • Hypericin: Photodynamic Antiviral Compound from St. John’s Wort (Hypericum perforatum)
      • Hyperforin
      • Hyperforin DCHA
      • Jervine: Steroidal Alkaloid Hedgehog Pathway Antagonist from Corn Lily (Veratrum californicum)
      • MLA
      • Muldamine: Steroidal Alkaloid from Corn Lily (Veratrum californicum)
      • Nobiletin: Polymethoxylated Flavone from Citrus Peel (Citrus sinensis)
      • Paclitaxel: Natural Anti-Mitotic Anticancer Compound from Yew (Taxus sp.)
      • Phloridzin Dihydrate: Dihydrochalcone SGLT Inhibitor from Apple Wood (Malus sp.)
      • Sclareolide: Sesquiterpene Lactone from Clary Sage (Salvia sclarea)
      • 6-Shogaol: Bioactive Compound from Ginger Root (Zingiber officinale)
      • Tangeretin: Bioflavonoid from Citrus Peel (Citrus sinensis)
      • Veratramine: Steroidal Alkaloid from Corn Lily (Veratrum californicum)
    • Equipment
    • Quality of Life Medicines
  • Technology
    • Enabling Technology Platforms
    • Drug Discovery
    • Drug Manufacturing
    • Drug Delivery
      • CFN
      • PNS
      • PNP
    • Drug Safety
      • CFI™ Mechanisms of Action & Applications
    • Microbial Cell Disruption
    • Crystallization
      • Natural Therapeutics Crystallization – CRY
      • SuperFluids Crystallization Process
    • Biomass Pretreatment
      • Cellulosic Biomass Pretreatment (CBP) – Aosic Platform
  • Investors
    • Investors Overview
      • Aphios Pharma LLC
      • Aphios International LLC
      • Zindol LLC
  • About
    • Company Overview
    • Management
    • Directors
    • Scientific Advisors
    • Community Involvement
    • Press Releases
    • Events
    • Careers
  • Contact
  • Shop

Press Releases

← Back to Press Releases

Aphios Granted US Patent for Thermal Conversion of CBDA and Other Carboxylic Acid Cannabinoids

North Reading, Mass. – January 15, 2025 − Aphios announced today that it was granted US Patent No. 11,981,174 for the  thermal conversion of CBDA to CBD and other carboxylic acid cannabinoids to cannabinoids.

The patent was granted for a process to improve the manufacturing of pharmaceutical grade CBD and other cannabinoids following current Good Manufacturing Practices (cGMP) of the US FDA.  The major cannabinoids in marijuana (Cannabis) originate from cannabigerolic acid (CBGA) and are converted by enzymes to different carboxylic acids of cannabinoids including cannabidiolic acid (CBDA) and Δ9-tetrahydrocannabinolic acid (Δ9-THCA).  These carboxylic acid cannabinoids are very stable in the growing and fresh-cut plants.

According to Dr. Trevor P. Castor, President and CEO, Aphios Pharma LLC, “Because of manufacturing efficiency and product stability, we first extract and purify carboxylic acid cannabinoids in a two-step supercritical fluid extraction and chromatographic purification process. We then convert the purified carboxylic acid cannabinoids into pure cannabinoids  in a low to medium-pressure reactor in an oxygen-free environment, maintaining product quality and reducing manufacturing costs.”

About Aphios Pharma LLC 

Aphios Pharma LLC is an emerging growth, green biotechnology company developing FDA-approved, cannabis-based drugs for treating highly unmet central and peripheral nervous system disorders of addiction, pain, anxiety, epilepsy and Multiple Sclerosis that are only partially and anecdotally addressed by medical marijuana in an environmentally sustainable manner.

Research reported in this press release was supported by the National Institute on Drug Abuse (NIDA) of the National Institutes of Health (NIH) under Award Number 5R44DA038932-03. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIDA and the National Institutes of Health.

Aphios

Inspired by Nature, Enabled by Science®

© 2026 Aphios Corporation

Contact Us

  • [email protected]
  • (781) 932-6933
  • 87 Main Street, North Reading, MA 01864 USA
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Instagram
  • Tik Tok